SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-061614
Filing Date
2023-03-06
Accepted
2023-03-06 17:28:46
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d472677d424b5.htm 424B5 460989
2 GRAPHIC g472677g01k32.jpg GRAPHIC 58032
3 GRAPHIC g472677g06f00.jpg GRAPHIC 81263
4 GRAPHIC g472677g11a65.jpg GRAPHIC 54195
  Complete submission text file 0001193125-23-061614.txt   724674
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-239734 | Film No.: 23710076
SIC: 2834 Pharmaceutical Preparations